2018
DOI: 10.1002/mp.12994
|View full text |Cite
|
Sign up to set email alerts
|

Dosimetric characterization of a new directional low‐dose rate brachytherapy source

Abstract: Primary S measurements of the CivaDot demonstrated good repeatability and reproducibility of the free-air chamber measurements. Measurements of the CivaDot dose distribution using the EBT3 film stack phantom and its subsequent comparison to Monte Carlo-predicted dose distributions were encouraging, given the overall uncertainties. This work will aid in the eventual realization of a clinically viable dosimetric framework for the CivaSheet based on the CivaDot dose distribution.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
12
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 8 publications
(14 citation statements)
references
References 30 publications
2
12
0
Order By: Relevance
“…"Static" techniques included any shielded technique in which the shield did not move relative to the source or regions of interest during treatment. The shield could be associated with the applicator or the source directly (subcategories "static-shielded applicators" [46][47][48][49] and "static-shielded sources," [53][54][55][56][57][58][59][60][61][62][63][64] respectively), but a given approach was not included if a static shield was solely associated with an OAR for its sparing and not with the source or applicator (eg, mandibular shields in head and neck BT). Techniques were considered "dynamic" if the shield was translated or rotated during treatment relative to the source or regions of interest as part of the treatment plan.…”
Section: Imbt Per Techniquementioning
confidence: 99%
See 2 more Smart Citations
“…"Static" techniques included any shielded technique in which the shield did not move relative to the source or regions of interest during treatment. The shield could be associated with the applicator or the source directly (subcategories "static-shielded applicators" [46][47][48][49] and "static-shielded sources," [53][54][55][56][57][58][59][60][61][62][63][64] respectively), but a given approach was not included if a static shield was solely associated with an OAR for its sparing and not with the source or applicator (eg, mandibular shields in head and neck BT). Techniques were considered "dynamic" if the shield was translated or rotated during treatment relative to the source or regions of interest as part of the treatment plan.…”
Section: Imbt Per Techniquementioning
confidence: 99%
“…1B), 53,56,57,59,61,64 or intraoperative BT for pancreatic, abdominopelvic, and colorectal cancer. 54,55,58,62,63 Lin et al introduced directional D-shaped 125 I sources with a 0.2 mm-thick gold shield for interstitial LDR-BT to achieve an angular uniform dose over a 180-degree sector around the axis of the source in the transverse plane. 60 They reported dosimetric validation results for breast cancer when compared with 192 Irbased high-dose-rate (HDR)-BT plans, and the treatmentplanning technique for the directional, D-shaped LDR source (Fig.…”
Section: Static-shielded Imbtmentioning
confidence: 99%
See 1 more Smart Citation
“…Under the assumption of a planar implant, the individual CivaDot strength to be ordered can be determined using published nomograms . Traceable air‐kerma strength measurements for this directional source are conducted using standard source acceptance protocol and equipment . It is, however, necessary to use a specially designed CivaDot holder that allows accurate source rotation around the axis of the well‐chamber, while preserving perpendicular orientation of the source surface and maintaining the location of the active volume on the axis …”
Section: Introductionmentioning
confidence: 99%
“…As a result, the value of Λ = 0.579(17) cGy/h/U is lower than that of an unshielded 103Pd source (typically about 0.68 cGy/h/U) . Radiochromic film measurements have been used to benchmark the directional source model, derived from MCNP6 Monte Carlo simulations …”
Section: Introductionmentioning
confidence: 99%